By inserting these modifications in the mRNA of JAK1, lactylated METTL3 strengthens the pro-tumoral JAK/STAT3 pathway and enhances tumor progression of colon cancer both in vitro and in vivo (31). Here, METTL3 is linked to neoplasm.